Prevalence of Human Papillomavirus Infection and Genotype Distribution Determined via Real-Time PCR in a Korean Medical Check-up Population
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Human papillomavirus (HPV) plays a critical role in the development of cervical carcinoma. This study analyzed the efficiency of multiplex real-time PCR in detecting and identifying HPV genotypes in samples from women who visited a Korean hospital for checkups. Cervical swab specimens were obtained from women who attended a checkup at the Health Improvement Center of Hospital in Dankook University Cheonan, South Korea and were referred for an HPV genotyping test between January and September 2014. A total of 1703 cervical swab specimens were collected consecutively during this period. PCR results were compared with those of the traditional cytological assay for the same population. Among the 1,703 specimens, 19.91% were HPV positive, of which 14.50% indicated a single infection and 5.40% indicated multiple infections. However, cytology identified only 2.52% of positive cases, including 1.23% cases of atypical squamous cells of undetermined significance, 1% of low grade squamous intra-epithelial lesion, and 0.29% of high grade squamous intra-epithelial lesion. The rate of high-risk and low-risk HPV in the abnormal cytology group was 48 and 23, respectively, and 274 and 136 in the normal group, respectively. HPV types 56, 52, 43 were the most prevalent in that order. Our results confirm the efficiency of the HPV DNA assay for the detection of 28 different HPV genotypes with reasonable sensitivity. A screening strategy that comprises the HPV DNA assay and cytology would help overcome the low sensitivity of a cytological diagnosis.
Abstract
Human papillomavirus (HPV) plays a critical role in the development of cervical carcinoma. This study analyzed the efficiency of multiplex real-time PCR in detecting and identifying HPV genotypes in samples from women who visited a Korean hospital for checkups. Cervical swab specimens were obtained from women who attended a checkup at the Health Improvement Center of Hospital in Dankook University Cheonan, South Korea and were referred for an HPV genotyping test between January and September 2014. A total of 1703 cervical swab specimens were collected consecutively during this period. PCR results were compared with those of the traditional cytological assay for the same population. Among the 1,703 specimens, 19.91% were HPV positive, of which 14.50% indicated a single infection and 5.40% indicated multiple infections. However, cytology identified only 2.52% of positive cases, including 1.23% cases of atypical squamous cells of undetermined significance, 1% of low grade squamous intra-epithelial lesion, and 0.29% of high grade squamous intra-epithelial lesion. The rate of high-risk and low-risk HPV in the abnormal cytology group was 48 and 23, respectively, and 274 and 136 in the normal group, respectively. HPV types 56, 52, 43 were the most prevalent in that order. Our results confirm the efficiency of the HPV DNA assay for the detection of 28 different HPV genotypes with reasonable sensitivity. A screening strategy that comprises the HPV DNA assay and cytology would help overcome the low sensitivity of a cytological diagnosis.
참고문헌 (49)
- An HJ, "Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method", Cancer, 97, pp.1672~1680 (2003)[DOI]
- 설현주, "Epidemiologic characteristics of cervical cancer in Korean women", Journal of Gynecologic Oncology, 25(1), pp.70~74 (2014), 대한부인종양학회
- Baudu A, "Prevalence and risk factors of human papillomavirus infection types 16", 18, J. Epidemiol. Glob. Health., pp.2014, 4[DOI]
- Grinsztejn B, "Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women", Int. J. Infect. Dis., 13, pp.72~80 (2009)[DOI]
- Clifford GM, "Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis", Br. J. Cancer., 88, pp.63~73 (2003)[DOI]
- Jun SY, "Comparison of the Cobas 4800 HPV and HPV 9G DNA chip tests for detection of high-risk human papillomavirus in cervical specimens of women with consecutive positive HPV tests but negative Pap smears", PLoS One, 10, pp.e0140336~ (2015)[DOI]
- 김재경, "Prevalence and Genotype Distribution of Human Papillomavirus in Cheonan, Korea", Journal of Microbiology and Biotechnology, 24(8), pp.1143~1147 (2014), 한국미생물·생명공학회[DOI]
- 이근화, "제주도에서 이루어진 자궁경부세포검사 결과와 HPV 감염양상 비교 연구", Obstetrics & Gynecology Science, 54(11), pp.689~695 (2011), 대한산부인과학회
- Parkin DM, "Cancer incidence in five continents. Comparability and quality of data", IARC Sci. Publ., 120, pp.45~173 (1992)
- Pytynia KB, "Epidemiology of HPV-associated oropharyngeal cancer", Oral. Oncol., 50, pp.380~386 (2014)[DOI]
- Franco EL, "Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer", J. Infect. Dis., 180, pp.1415~1423 (1999)[DOI]
- Woodman CB, "Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study", Lancet, 357, pp.1831~1836 (2001)[DOI]
- Rosales R, "Immune therapy for human papillomaviruses-related cancers", World. J. Clin. Oncol., 5, pp.1002~1019 (2014)[DOI]
- 김윤지, "Prevalence of Human Papillomavirus Infection and Genotype Distribution Determined by the Cyclic-Catcher Melting Temperature Analysis in Korean Medical Checkup Population", The Journal of Microbiology, 51(5), pp.665~670 (2013), 한국미생물학회[DOI]
- Chen Q, "Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China", PLoS One, 7, pp.e32149~ (2012)[DOI]
- Hwang HS, "Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip", Cancer. Epidemiol. Biomarkers. Prev., 13, pp.2153~2156 (2004)
- Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N. Engl. J. Med., 348, pp.518~527 (2003)[DOI]
- Bosch FX, "Chapter 1: human papillomavirus and cervical cancer--burden and assessment of causality", J. Natl. Cancer. Inst. Monogr., 31, pp.3~13 (2013)
- Estrade C, "Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes", J. Clin. Microbiol., 49, pp.3474~3481 (2011)[DOI]
- Vidal AC, "Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women", Infect. Agent. Cancer., 6, pp.20~ (2011)[DOI]
- Cox JT, "Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance", Am. J. Obstet. Gynecol., 172, pp.946~954 (1995)[DOI]
- Cuzick J, "New technologies and procedures for cervical cancer screening", Vaccine, 30, pp.F107~F116 (2012)[DOI]
- Nobbenhuis MA, "Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia", Br. J. Cancer., 84, pp.796~801 (2001)[DOI]
- Rabaan AA, "Comparison of Xpert(R) HPV and Hybrid Capture(R) 2 DNA TestTM for detection of high-risk HPV infection in cervical atypical squamous cells of undetermined significance", J. Infect. Public. Health., 10, pp.219~223 (2017)[DOI]
- Cho NH, "Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis", Am. J. Obstet. Gynecol., 188, pp.56~62 (2003)[DOI]
- Nyitray AG, "The epidemiology of human papillomaviruses", Curr. Probl. Dermatol., 45, pp.75~91 (2014)
- Seoud M, "Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review", J. Low. Genit. Tract. Dis., 16, pp.106~120 (2012)[DOI]
- Clifford GM, "Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis", Lancet, 366, pp.991~998 (2005)[DOI]
- de Sanjose S, "Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis", Lancet. Infect. Dis., 7, pp.453~459 (2007)[DOI]
- Shin HR, "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea", J. Infect. Dis., 190, pp.468~476 (2004)[DOI]
- Gargiulo F, "Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women", Virus. Res., 125, pp.176~182 (2007)[DOI]
- 정소이, "건강증진센터를 방문하는 여성의 인유두종바이러스의 유병률 및 유전형의 분포와 자궁이형성증과의 관계", Annals of Clinical Microbiology, 16(2), pp.87~91 (2013), 대한임상미생물학회[DOI]
- Bosch FX, "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group", J. Natl. Cancer. Inst., 87, pp.796~802 (1995)[DOI]
- Castellsague X, "Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention", J. Natl. Cancer. Inst., 98, pp.303~315 (2006)[DOI]
- 신은심, "사람유두종바이러스의 검출과 유전자형 분석을 위한 HPV28 Detection 검사와 HPV DNA Chip 검사의 비교 평가", Laboratory Medicine Online, 3(4), pp.234~241 (2013), 대한진단검사의학회
- Shin HR, "Prevalence of human papillomavirus infection in women in Busan, South Korea", Int. J. Cancer., 103, pp.413~421 (2003)[DOI]
- Chen HC, "Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer", J. Natl. Cancer. Inst., 103, pp.1387~1396 (2011)[DOI]
- Dalstein V, "Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study", Int. J. Cancer., 106, pp.396~403 (2003)[DOI]
- Ho GY, "Natural history of cervicovaginal papillomavirus infection in young women", N. Engl. J. Med., 338, pp.423~428 (1998)[DOI]
- Nobbenhuis MA, "Relation of human papillomavirus status to cervical lesions and consequences for cervicalcancer screening: a prospective study", Lancet, 354, pp.20~25 (1999)[DOI]
- Wallin KL, "Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer", N. Engl. J. Med., 341, pp.1633~1638 (1999)[DOI]
- Gervais F, "Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend", BMC Public. Health., 17, pp.283~ (2017)[DOI]
- Lu JF, "Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China", BMC. Infect. Dis., 17, pp.226~ (2017)[DOI]
- Menon S, "Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population", Infect. Agent. Cancer, 12, pp.2~ (2017)[DOI]
- Chan PK, "High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions", J. Med. Virol., 59, pp.232~238 (1999)[DOI]
- Sasagawa T, "High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women", Cancer. Epidemiol. Biomarkers. Prev., 10, pp.45~52 (2001)
- Chang DY, "Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia", J. Med. Microbiol., 46, pp.54~60 (1997)[DOI]
- Trottier H, "Human papillomavirus and cervical cancer: burden of illness and basis for prevention", Am. J. Manag. Care., 12, pp.S462~S472 (2006)
- Trottier H, "Human papillomavirus infections with multiple types and risk of cervical neoplasia", Cancer. Epidemiol. Biomarkers. Prev., 15, pp.1274~1280 (2006)[DOI]
